SPECT scan

DRUG2 trials

Sponsors

Institute for Neurodegenerative Disorders, Royal Marsden NHS Foundation Trust

Conditions

Alzheimer DiseaseMetastatic Sites Lung Bone NodalThyroid Carcinoma

Phase 1

Evaluation of [123I] AV151 and SPECT in Subjects w/ AD in Comparison to Healthy Subjects

TerminatedNCT00605046

Institute for Neurodegenerative DisordersAlzheimer Disease

Start: 2007-08-31End: 2008-06-30Updated: 2010-10-06

Unknown Phase

Radioiodine Dosimetry Protocol for Thyroid Cancer Metastases

Royal Marsden NHS Foundation TrustMetastatic Sites Lung Bone Nodal, Thyroid Carcinoma

Start: 2008-05-31End: 2010-07-31Target: 10Updated: 2008-09-09